IL102922A0IL102922AIL10292292AIL102922A0IL 102922 A0IL102922 A0IL 102922A0IL 102922 AIL102922 AIL 102922AIL 10292292 AIL10292292 AIL 10292292AIL 102922 A0IL102922 A0IL 102922A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
xanthine derivatives
containing xanthine
derivatives
Prior art date
Application number
IL102922A
Original Assignee
Hoechst Roussel Pharma
Univ Virginia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/131,785external-prioritypatent/US4965271A/en
Application filed by Hoechst Roussel Pharma, Univ VirginiafiledCriticalHoechst Roussel Pharma
Priority to IL102922ApriorityCriticalpatent/IL102922A0/en
Publication of IL102922A0publicationCriticalpatent/IL102922A0/en
Pharmaceutical formulations containing 1,3-disubstituted-7- (oxohydrocarbyl) xanthine derivatives for inhibiting the activity of leukocyte- derived cytokines